The FTC has given a green light to the Merck& Co. Schering-Plough merger on the condition that Merck divest its stake in Merial Ltd an animal health joint venture with Sanofi-Aventis, and Schering divests its assets associated with nausea drugs for humans. Both companies are reported to be in the process of compiling with the divestitures in order to allow the merger to proceed.